Skip to main content
The Markets by Proactive
Go to Proactive Australia

Archive

IXICO chosen to provide services for second Alzheimer’s clinical trial in the span of one week

IXICO chosen to provide services for second Alzheimer’s clinical trial in the span of one week

IXICO PLC (LON:IXI) Chief Commercial Officer Lammert Albers tells Proactive the neuro-imaging specialist has been chosen to support an Alzheimer’s clinical trial; its second contract in this field in the space of just over a week.

Albers says what's more, the AD/PD 2021, Alzheimer's & Parkinson's Diseases Conference is being held this week, where many scientists from pharma companies are presenting on their own clinical assets on development.